Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 6 minute read General business news WisdomTree’s Atlantic House deal highlights rising demand for outcome-based ETFs (NYSE: WT) WisdomTree is acquiring Atlantic House to expand derivatives-driven ETF capabilities. Discover what the deal means for the ETF industry and investors. bySoujanya RaviMarch 16, 2026